These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 10432380)

  • 1. A novel apolipoprotein E mutation, E2 (Arg25Cys), in lipoprotein glomerulopathy.
    Matsunaga A; Sasaki J; Komatsu T; Kanatsu K; Tsuji E; Moriyama K; Koga T; Arakawa K; Oikawa S; Saito T; Kita T; Doi T
    Kidney Int; 1999 Aug; 56(2):421-7. PubMed ID: 10432380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel 18-amino acid deletion in apolipoprotein E associated with lipoprotein glomerulopathy.
    Ando M; Sasaki J; Hua H; Matsunaga A; Uchida K; Jou K; Oikawa S; Saito T; Nihei H
    Kidney Int; 1999 Oct; 56(4):1317-23. PubMed ID: 10504484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma level and genetic variation of apolipoprotein E in patients with lipoprotein glomerulopathy.
    Zhang B; Liu ZH; Zeng CH; Zheng JM; Chen HP; Zhou H; Li LS
    Chin Med J (Engl); 2005 Apr; 118(7):555-60. PubMed ID: 15820086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel glomerular lipoprotein deposits associated with apolipoprotein E2 homozygosity.
    Sakatsume M; Kadomura M; Sakata I; Imai N; Kondo D; Osawa Y; Shimada H; Ueno M; Miida T; Nishi S; Arakawa M; Gejyo F
    Kidney Int; 2001 May; 59(5):1911-8. PubMed ID: 11318963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of a novel 3-amino acid deletion mutation of apolipoprotein E (Apo E Tokyo) with lipoprotein glomerulopathy.
    Konishi K; Saruta T; Kuramochi S; Oikawa S; Saito T; Han H; Matsunaga A; Sasaki J
    Nephron; 1999; 83(3):214-8. PubMed ID: 10529627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disappearance of intraglomerular lipoprotein thrombi and marked improvement of nephrotic syndrome by bezafibrate treatment in a patient with lipoprotein glomerulopathy.
    Arai T; Yamashita S; Yamane M; Manabe N; Matsuzaki T; Kiriyama K; Kanayama Y; Himeno S; Matsuzawa Y
    Atherosclerosis; 2003 Aug; 169(2):293-9. PubMed ID: 12921981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E Sendai (arginine 145-->proline): a new variant associated with lipoprotein glomerulopathy.
    Oikawa S; Matsunaga A; Saito T; Sato H; Seki T; Hoshi K; Hayasaka K; Kotake H; Midorikawa H; Sekikawa A; Hara S; Abe K; Toyota T; Jingami H; Nakamura H; Sasaki J
    J Am Soc Nephrol; 1997 May; 8(5):820-3. PubMed ID: 9176854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a novel variant of apolipoprotein E, E2 Fukuoka (Arg-224 --> Gln) in a hyperlipidemic patient with xanthomatosis.
    Moriyama K; Sasaki J; Takada Y; Arakawa F; Matsunaga A; Ito Y; Arakawa K
    Biochim Biophys Acta; 1996 Jun; 1301(3):185-90. PubMed ID: 8664327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Identification of a mutation in exon 4 of apolipoprotein E gene in a family affected with lipoprotein glomerulopathy].
    Han HL; Lin S; Sun LS; Zhang P; Zhai DP
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Apr; 29(2):141-4. PubMed ID: 22487820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe type III hyperlipoproteinemia associated with unusual apolipoprotein E1 phenotype and epsilon 1/'null' genotype.
    Feussner G; Funke H; Weng W; Assmann G; Lackner KJ; Ziegler R
    Eur J Clin Invest; 1992 Sep; 22(9):599-608. PubMed ID: 1360898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of apolipoprotein E polymorphism with lipoprotein glomerulopathy. Report of 2 cases with a new genotype and comparison of the relative frequencies of apolipoprotein E isoforms in lipoprotein glomerulopathy and in the general population.
    Yang AH; Ng YY; Tarng DC; Chen JY; Shiao MS; Kao JT
    Nephron; 1998; 78(3):266-70. PubMed ID: 9546684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel mutation ApoE2 Kurashiki (R158P) in a patient with lipoprotein glomerulopathy.
    Tokura T; Itano S; Kobayashi S; Kuwabara A; Fujimoto S; Horike H; Satoh M; Komai N; Tomita N; Matsunaga A; Saito T; Sasaki T; Kashihara N
    J Atheroscler Thromb; 2011; 18(6):536-41. PubMed ID: 21467726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel electrophoretic variant of human apolipoprotein E. Identification and characterization of apolipoprotein E1.
    Weisgraber KH; Rall SC; Innerarity TL; Mahley RW; Kuusi T; Ehnholm C
    J Clin Invest; 1984 Apr; 73(4):1024-33. PubMed ID: 6323533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein glomerulopathy associated with psoriasis vulgaris: report of 2 cases with apolipoprotein E3/3.
    Chang CF; Lin CC; Chen JY; Yang AH; Shiao MS; Kao JT; Yang WC
    Am J Kidney Dis; 2003 Sep; 42(3):E18-23. PubMed ID: 12955707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A founder haplotype of APOE-Sendai mutation associated with lipoprotein glomerulopathy.
    Toyota K; Hashimoto T; Ogino D; Matsunaga A; Ito M; Masakane I; Degawa N; Sato H; Shirai S; Umetsu K; Tamiya G; Saito T; Hayasaka K
    J Hum Genet; 2013 May; 58(5):254-8. PubMed ID: 23407349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A complete genomic analysis of the apolipoprotein E gene in Chinese patients with lipoprotein glomerulopathy.
    Chen S; Liu ZH; Zheng JM; Zhang X; Li LS
    J Nephrol; 2007; 20(5):568-75. PubMed ID: 17918142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Novel Apolipoprotein E Mutation ApoE Chengdu (c.518T＞C, p.L173P) in a Chinese Patient with Lipoprotein Glomerulopathy.
    Wu H; Yang Y; Hu Z
    J Atheroscler Thromb; 2018 Aug; 25(8):733-740. PubMed ID: 29398675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A patient with apolipoprotein E2 variant (Q187E) without lipoprotein glomerulopathy.
    Hayakawa M; Okubo M; Katori H; Nagahama K; Murase T; Kobayashi T; Tanaka S; Nakanishi K; Odawara M; Matsushita H; Yamada A
    Am J Kidney Dis; 2002 Mar; 39(3):E15. PubMed ID: 11877595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of apolipoprotein E genotype on the reliability of the Friedewald formula in the estimation of low-density lipoprotein cholesterol concentrations.
    Tremblay AJ; Bergeron J; Gagné JM; Gagné C; Couture P
    Metabolism; 2005 Aug; 54(8):1014-9. PubMed ID: 16092050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein e mutation and double filtration plasmapheresis therapy on a new Chinese patient with lipoprotein glomerulopathy.
    Li W; Wang Y; Han Z; Luo C; Zhang C; Xiong J
    Kidney Blood Press Res; 2014; 39(4):330-9. PubMed ID: 25300642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.